Vantrexa · NSCLC · Japan · Pathologist · captured by Mei Tanaka on 13 Sept 2026
Verbatim as captured; never edited
Pathologist at Osaka University noted that regional hospitals send PD-L1 samples to central labs with a 10–14 day turnaround, and that oncologists often start chemotherapy before results return. She suggested a Japanese-language testing pathway guide and reflex-testing advocacy at JSMO.
Awaiting human review
Japanese regional PD-L1 turnaround of 10–14 days leads to chemotherapy initiation before results. Suggests Japanese testing-pathway guide and reflex-testing advocacy.
helixor-private-llm-2026.08 · generated 13 Sept 2026, 04:31 UTC
AI summary
Regional PD-L1 TAT 10–14 days in Japan; chemo initiated before results. Requests Japanese pathway guide.
Source spans used by the model
Pathologist at Osaka University noted that regional hospitals send PD-L1 samples to central labs with a 10–14 day turnaround, and that oncologists often start chemotherapy before results return. She suggested a Japanese-language testing pathway guide and reflex-testing advocacy at JSMO.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Diagnosis and screening | Diagnosis and screening |
| Function | Medical Affairs | Medical Affairs |
| Priority | High | Critical |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 5 | 20% | 20.0 |
| Strategic alignment | 5 | 20% | 20.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 2 | 10% | 4.0 |
| Actionability | 5 | 10% | 10.0 |
| Confidence | 4 | 5% | 4.0 |
| Breadth of occurrence | 3 | 5% | 3.0 |
| Total | Critical 82 | ||
No audit events in sample data
Every model call on this record and its human outcome
| Time | Feature | Model | User | Confidence | Outcome |
|---|---|---|---|---|---|
| 13 Sept 2026, 04:31 UTC | Topic classification | helixor-private-llm-2026.08 | Mei Tanaka | 88% | Pending review |
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
13 Sept 2026 · Dr. Tomoko Ueda, Osaka University Hospital · MSL Mei Tanaka
Insight
Not yet reviewed
Action
Initiative
Decision
Outcome
Closure